NCT00341848 is a clinical trial in Uterine Leiomyoma, sponsored by National Institute of Environmental Health Sciences (NIEHS).

Who is sponsoring NCT00341848?

NCT00341848 is sponsored by National Institute of Environmental Health Sciences (NIEHS).

What condition does NCT00341848 study?

NCT00341848 studies Uterine Leiomyoma.

Is NCT00341848 still recruiting?

NCT00341848 is currently completed. Last updated 17 June 2019.

Last reviewed 2019-06-17 · How we verify

NCT00341848

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Postpartum Uterine Regression

Completed Last updated 17 June 2019

What this trial tests

trial in Uterine Leiomyoma in 374 participants. Completed in 13 June 2019.

Timeline

6 December 2001

13 June 2019

Quick facts

Lead sponsor	National Institute of Environmental Health Sciences (NIEHS)
Status	Completed
Study type	OBSERVATIONAL
Enrollment	374
Start date	6 December 2001
Estimated completion	13 June 2019
Sites	1 location across United States

Conditions studied

Uterine Leiomyoma — all drugs for Uterine Leiomyoma →

Sponsor

National Institute of Environmental Health Sciences (NIEHS)

Who can join

Adults 18 to 45, female only, with Uterine Leiomyoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Uterine leiomyomas are the leading cause of hysterectomy in the United States, accounting for over 200,000 procedures each year. Most epidemiologic studies of uterine leiomyoma show that parity has a protective association with leiomyoma, but the mechanism is not known. Both epidemiologic data and data from an animal model indicate that the protective association is not an artifact resulting from reduced fertility among women with fibroids. We hypothesize that the process of uterine regression following delivery results in loss of small fibroids due to selective apoptosis of transformed cells and the extensive remodeling of the entire uterus.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other National Institute of Environmental Health Sciences (NIEHS) trials

Trials by the same sponsor.

NCT07111065 — FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM) · Phase 2 · recruiting
NCT06991751 — A Natural History of Cardiometabolic Disease Among US Bhutanese: Developing the Cross-Sectional Bhutanese Community of C · not yet recruiting
NCT07437976 — A Natural History of Genetic and Environmental Predictors of Pubertal Timing Among Youth With Obesity · not yet recruiting
NCT06325696 — H01 in Adults With Interstitial Lung Disease (The SOLIS Study) · Phase 2 · recruiting
NCT05666739 — NIEHS Repository of Stored Biological Samples for Future Use · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00341848 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Institute of Environmental Health Sciences (NIEHS)
Last refreshed: 17 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00341848.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing